Withdrawal of cautionary announcement
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) ("Aspen Holdings")
Registration number: 1985/002935/06
Share code: APN
and its subsidiaries (collectively "Aspen" or "the Company")
WITHDRAWAL OF CAUTIONARY ANNOUNCEMENT
Further to the cautionary announcement dated 22 May 2019, wherein the Company advised shareholders
that it was engaged in exclusive discussions with a potential partner in Europe as part of the strategic
review of its European Commercial Pharmaceuticals business, shareholders are now advised that those
discussions have been terminated and as a result caution is no longer required to be exercised when
dealing in the Company's securities.
Shareholders are advised that Aspen is now in a position to explore options with other potential partners in
order to optimise its European Commercial Pharmaceuticals business.
05 July 2019
Investec Bank Limited
Date: 05/07/2019 08:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.